Capital Fund Management (CFM)
WST icon

Capital Fund Management (CFM)’s West Pharmaceutical WST Stock Holding History

Capital Fund Management (CFM)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,600
Closed -$936K – 2071
2019
Q3 		$936K Buy
6,600
+2,800
+74% +$386K 0.01% 1046
2019
Q2 		$476K Buy
+3,800
New +$449K ﹤0.01% 1233

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Fund Management (CFM)'s WST Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 32,249 shares — an estimated $8.08M sold.

Capital Fund Management (CFM) first reported a position in WST in Q1 2014 and held it in 26 quarters. The position peaked at $30.5M in Q2 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 32,249 West Pharmaceutical shares in Q2 2026, an estimated $8.08M.
  • Capital Fund Management (CFM) first reported a position in West Pharmaceutical in Q1 2014 and held it in 26 quarters.
  • Capital Fund Management (CFM)'s West Pharmaceutical position peaked at $30.5M in Q2 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.